On June 13th, the US Supreme Court ruled in favor of the United States in a case that challenged the availability of mifepristone. This episode provides a straightforward recap of the court ruling and what it means for pharmacists.

The GameChanger
Pharmacists should understand legal boundaries and ethical considerations surrounding medications like mifepristone to provide safe, compliant, and patient-centered care.

Host
Jen Moulton, BSPharm
President, CEimpact

Guest
David Brushwood, RPh, JD
Senior Lecturer
University of Wyoming

Reference
Supreme Court Document on Ruling
Supreme Court preserves access to abortion pill

Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the historical context and legal evolution of mifepristone regulation by the FDA, including key changes and their implications for pharmacy practice.

2. Identify the ethical responsibilities and state and federal legal requirements when dispensing medications such as mifepristone.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-209-H03-P
Initial release date: 06/24/2024
Expiration date: 06/24/2025
Additional CPE details can be found here.